Related Experiment Video
Updated: Aug 19, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
What is holding back glucometer use? -A comparative study of rural and urban India
Vinaytosh Mishra1, Lemai Nguyen2, Nilmini Wickramasinghe3
1College of Healthcare Management and Economics, Gulf Medical University, Ajman, United Arab Emirates.
Background:
Self-monitoring of blood glucose (SMBG) is associated with better glycemic control. There have been significant technological advances in blood glucose monitoring in the recent past, but the wider acceptance of these technologies is still debatable.
Aim:
This study investigates the adoption of glucometers and the extent of the use of features in rural and urban India.
Methods:
The study uses Bass Model to predict the diffusion of innovation (DOI). Mathematical modeling was used to determine the stage of adoption (using 5-stage of DOI) and the Chi-Square test was used for examining the relationship between depth of implementation (extent of use) and place of residence.
Results:
The result of the study suggests that glucometer diffusion of innovation has passed the initial hurdle (chasm) in the urban population and is in the late majority. However, for rural respondents, the adoption of glucometers has just passed the chasm and falls under the early majority stage. The diffusion of innovation of combined rural and urban populations has just entered the late majority zone in 2022. The study suggests that a significant number of people with diabetes are still not using a glucometer and discusses the socio-economic issue related to this phenomenon. The utilization of the potential of a glucometer in SMBG falls under the localized shallow implementation category (not using advanced features).
Conclusions:
The study suggests that the adoption of glucometer has just passed the initial hurdle in rural India, where two-thirds of the Indian population lives. Furthermore, the adoption of advanced glucometers is low among users.
More Related Videos
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon